EYWN fundamentals
An in-depth look to BioMerieux operating, investing, and financing activities
EYWN free cash flow for H2 23 is 109.5 M EUR. For 2023, EYWN free cash flow was 107.1 M EUR and operating cash flow was 445.4 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM